| Wuxi Apptec Co., Ltd. Class A | 332K | US$6.51M | 9.1% |
| Beone Medicines Ltd. Class A | 22,890 | US$6.3M | 8.8% |
| Innovent Biologics, Inc. | 618K | US$6.27M | 8.8% |
| Wuxi Biologics (cayman) Inc. | 1.21M | US$5.35M | 7.5% |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A | 426K | US$3.27M | 4.6% |
| Shenzhen Mindray Bio-medical Electronics Co., Ltd. Class A | 152K | US$3.04M | 4.3% |
| Akeso, Inc. | 236K | US$2.65M | 3.7% |
| Cspc Pharmaceutical Group Limited | 2.95M | US$2.62M | 3.7% |
| Sino Biopharmaceutical Limited | 4.29M | US$2.41M | 3.4% |
| Hansoh Pharmaceutical Group Company Limited | 538K | US$2.03M | 2.9% |
| 3sbio, Inc. | 823K | US$1.77M | 2.5% |
| Remegen Co. Ltd. Class A | 156K | US$1.64M | 2.3% |
| Yunnan Baiyao Group Co. Ltd. Class A | 235K | US$1.64M | 2.3% |
| Shanghai United Imaging Healthcare Co., Ltd. Class A | 109K | US$1.62M | 2.3% |
| Aier Eye Hospital Group Co., Ltd. Class A | 1.23M | US$1.49M | 2.1% |
| Sichuan Biokin Pharmaceutical Co., Ltd. Class A | 32,322 | US$1.4M | 2.0% |
| Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H | 23,700 | US$1.32M | 1.9% |
| Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A | 80,134 | US$1.29M | 1.8% |
| Sinopharm Group Co., Ltd. Class H | 587K | US$1.19M | 1.7% |
| Sichuan Kelun Pharmaceutical Co., Ltd. Class A | 203K | US$1.15M | 1.6% |
| Haisco Pharmaceutical Group Co. Ltd. Class A | 111K | US$1.09M | 1.5% |
| Huadong Medicine Co., Ltd. Class A | 234K | US$969K | 1.4% |
| Wuxi Xdc Cayman, Inc. | 133K | US$964K | 1.4% |
| Shanghai Allist Pharmaceuticals Co. Ltd. Class A | 59,328 | US$954K | 1.3% |
| Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A | 460K | US$927K | 1.3% |
| Shanghai Pharmaceuticals Holding Co. Ltd. Class A | 583K | US$833K | 1.2% |
| Pharmaron Beijing Co., Ltd. Class A | 280K | US$818K | 1.1% |
| Genscript Biotech Corporation | 508K | US$792K | 1.1% |
| China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A | 221K | US$731K | 1.0% |
| Xtalpi Holdings Limited | 727K | US$709K | 1.00% |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A | 148K | US$694K | 0.97% |
| Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A | 104K | US$643K | 0.90% |
| Beijing Tongrentang Co., Ltd. Class A | 180K | US$614K | 0.86% |
| Shanghai Raas Blood Products Co., Ltd. Class A | 876K | US$560K | 0.79% |
| Chongqing Zhifei Biological Products Co., Ltd. Class A | 315K | US$543K | 0.76% |
| Cspc Innovation Pharmaceutical Co., Ltd. Class A | 132K | US$529K | 0.74% |
| Changchun High-tech Industry (group) Co., Ltd. Class A | 53,708 | US$527K | 0.74% |
| Imeik Technology Development Co., Ltd. Class A | 39,840 | US$512K | 0.72% |
| Apt Medical Inc. Class A | 18,599 | US$497K | 0.70% |
| Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A | 120K | US$479K | 0.67% |
| Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Class A | 117K | US$402K | 0.56% |
| Hangzhou Tigermed Consulting Co., Ltd. Class A | 67,680 | US$324K | 0.46% |
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A | 0 | US$0 | 0.00% |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class A | 0 | US$0 | 0.00% |
| Shandong Weigao Group Medical Polymer Co. Ltd. Class H | 0 | US$0 | 0.00% |